Study: Benefits of Cannabinoids Extend Beyond Spasticity in Those With Multiple Sclerosis
The Joint Blog
APRIL 27, 2020
tetrahydocannabinol (THC)+cannabidiol (CBD) oromucosal spray (Sativex®) in Italy as an add-on medication for the management of moderate to severe spasticity in multiple sclerosis (MS) has provided a new opportunity for MS patients with drug-resistant spasticity”, states the study. We found that 627 (43.8%
49 
Let's personalize your content